Exponent Inc. (NASDAQ:EXPO) shares saw unusually-high trading volume on Friday . Approximately 184,189 shares changed hands during mid-day trading, an increase of 83% from the previous session’s volume of 100,715 shares.The stock last traded at $58.22 and had previously closed at $57.69.

EXPO has been the topic of a number of research analyst reports. Zacks Investment Research cut Exponent from a “buy” rating to a “hold” rating in a research note on Tuesday, April 5th. Avondale Partners assumed coverage on Exponent in a research note on Thursday. They set a “market perform” rating and a $60.00 price objective on the stock.

The company has a market cap of $1.51 billion and a P/E ratio of 32.71. The company has a 50-day moving average price of $55.20 and a 200 day moving average price of $50.50.

Exponent (NASDAQ:EXPO) last announced its quarterly earnings data on Wednesday, April 20th. The company reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.35 by $0.05. During the same quarter last year, the company posted $0.75 EPS. The company had revenue of $79 million for the quarter, compared to analyst estimates of $77.15 million. Exponent’s revenue was up 3.8% on a year-over-year basis. On average, equities analysts expect that Exponent Inc. will post $1.84 EPS for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, June 24th. Stockholders of record on Friday, June 10th were given a dividend of $0.18 per share. The ex-dividend date of this dividend was Wednesday, June 8th. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.24%.

In other Exponent news, VP Robert D. Caligiuri sold 2,500 shares of the business’s stock in a transaction on Monday, May 9th. The shares were sold at an average price of $50.00, for a total transaction of $125,000.00. Following the sale, the vice president now directly owns 130,812 shares of the company’s stock, valued at approximately $6,540,600. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Paul R. Johnston sold 5,578 shares of the business’s stock in a transaction on Friday, July 8th. The shares were sold at an average price of $58.15, for a total transaction of $324,360.70. Following the sale, the chief executive officer now directly owns 64,458 shares in the company, valued at $3,748,232.70. The disclosure for this sale can be found here.

A number of hedge funds have recently made changes to their positions in EXPO. California State Teachers Retirement System increased its stake in shares of Exponent by 1.6% in the fourth quarter. California State Teachers Retirement System now owns 48,123 shares of the company’s stock valued at $2,404,000 after buying an additional 770 shares during the period. First Trust Advisors LP increased its stake in shares of Exponent by 74.9% in the fourth quarter. First Trust Advisors LP now owns 26,087 shares of the company’s stock valued at $1,303,000 after buying an additional 11,171 shares during the period. Rhumbline Advisers increased its stake in shares of Exponent by 6.3% in the fourth quarter. Rhumbline Advisers now owns 33,165 shares of the company’s stock valued at $1,657,000 after buying an additional 1,980 shares during the period. California Public Employees Retirement System increased its stake in shares of Exponent by 11.6% in the fourth quarter. California Public Employees Retirement System now owns 106,400 shares of the company’s stock valued at $5,315,000 after buying an additional 11,100 shares during the period. Finally, Comerica Bank increased its stake in shares of Exponent by 0.7% in the fourth quarter. Comerica Bank now owns 27,900 shares of the company’s stock valued at $1,322,000 after buying an additional 203 shares during the period.

Exponent, Inc, along with its subsidiaries, is a science and engineering consulting company. The Company operates through two segments: Engineering and Other Scientific, and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, engineering management consulting, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, technology development, thermal sciences and vehicle analysis services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.